Archive -Daily News

CRISPR Therapy

CRISPR : 2017November13Monday

CRISPR Can Now Edit Genes Using Nanoparticles Instead of Viruses

CRISPR, Bayer JV tap CureVac for Cas9 mRNA constructs

New CRISPR Kits Simplify Gene Editing

Excision BioTherapeutics Licenses New CRISPR Systems from UC Berkeley

Novartis, already up on CRISPR, CAR-T, looks to new gene editing R&D

The quest to make CRISPR gene editing as easy as a smartphone app

Cellecta Licenses CRISPR IP From ERS Genomics

CRISPR THERAPEUTICS AG (NASDAQ:CRSP) Files An 8-K Departure of Directors or Certain Officers; Election of ...

When Will We Have Designer Babies?

CRISPR THERAPTC (CRSP) vs. Editas Medicine (NASDAQ:EDIT) Critical Review

Genetic Engineering: 2017November13Monday

Genetic engineering mechanism visualized

Could genetic engineering save the Galápagos?

Researchers Generate Tomatoes with Enhanced Antioxidant Properties by Genetic Engineering

What Are Consumers Willing To Pay For? A Preliminary Study On Chocolate Offers Surprising Insights

Scientists save child's life by growing him new skin

GMO Potatoes Provide Improved Vitamin A and E Profiles

Genetic engineering 'fastest method' to save Florida citrus industry from greening disease

The quest to make CRISPR gene editing as easy as a smartphone app

What Is a GMO?

Quirks & Quarks

Gene Editing : 2017November13Monday

Nanotech, gene editing used to edit cholesterol gene: US study

Novartis taps Homology Medicines for viral-based gene editing

Novartis, already up on CRISPR, CAR-T, looks to new gene editing R&D

Brainstorm Health: Trump HHS Pick, Cholesterol Gene Editing, Bill Gates Dementia Funding

CRISPR Therapeutics and Casebia Collaborate with CureVac on mRNA for Gene-Editing Programs

New CRISPR Kits Simplify Gene Editing

The quest to make CRISPR gene editing as easy as a smartphone app

New bioresources for plant peptide hormones using gene editing technology

Innovation meets precaution: NGO delay tactics hinder gene-editing revolution in Europe

Gene Editing Markets Research Report 2017: The Next Breakthrough in Regenerative Medicine - Research and Markets

CRISPR Therapy : 2017November13Monday

Novartis, already up on CRISPR, CAR-T, looks to new gene editing R&D

Interview with Francis Mojica, the Spanish Scientist that Discovered CRISPR

CRISPR Can Now Edit Genes Using Nanoparticles Instead of Viruses

CAR T-Cell Therapy Hits Prime Time; Challenges Remain

Novartis taps Homology Medicines for viral-based gene editing

When Will We Have Designer Babies?

Gene therapy and grafts regrow skin of boy with incurable skin-peeling disease

Quirks & Quarks

Abeona Management to Present at Multiple Conferences in November

Genome Editing Market Is Projected To Attain Value Of $8.1 Billion By 2025: Grand View Research, Inc.